The Myeloproliferative Neoplasms Channel is supported with funding from Takeda (Gold) and Kartos Therapeutics, Inc. (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
Texas MPN Workshop 2022 | Signaling pathways activated in MPNs: targeting the DUSP6-RSK1 pathway
Stephen Oh
• 27 Aug 2022
In this video, Stephen Oh, MD, PhD, Washington University School of Medicine, St. Louis, MO, shares some insights into signaling pathways involved in the development and progression of myeloproliferative neoplasms (MPNs), drawing focus on the DUSP6-RSK1 pathway. This interview took place at the third annual Texas MPN Workshop (TMW) 2022, held in San Antonio, TX.
